List of works - Yann Godet

A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes

scientific article published on 21 December 2007

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients

scientific article

An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.

scientific article published on March 2010

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

scientific article

CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes.

scientific article

Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas

scientific article

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

scientific article published on January 2015

Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy

scientific article published in June 2010

Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTL.

scientific article

IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.

scientific article published on 27 May 2016

Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine

scientific article

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer

scientific article published on 17 October 2012

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

scientific article published on 28 July 2006

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine

scientific article

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

scientific article published on December 2012

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.

scientific article

New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

scientific article published on January 2015

Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma

scientific article published on 12 January 2015

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

scientific article published on 17 May 2016

Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.

scientific article published on 28 January 2013

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination

scientific article published on March 2013

List of works by Yann Godet

A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients

An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes.

Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy

Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTL.

IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.

Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.

New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination